Therefore, we speculate that the m6A methylation-related genes IGFBP2 and METTTL3 may influence the interaction between SFs by regulating the neuropeptides GHR and NPR2, thus contributing to disease progression in RA. This evidence concerns the gene IGFBP2 and rheumatoid arthritis.